Novo Nordisk wins case in US appeals court
Three pharmaceutical firms, including Novo Nordisk, have won a case in a US appeals court, which agreed that the drugmakers can limit deliveries of federally discounted drugs.
by marketwire, translated by daniel pedersen
The Third Circuit Court of Appeals in Philadelphia, the US, has sided with a group of pharmaceutical firms, including Novo Nordisk.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Bank expects strong 2022 conclusion from Novo Nordisk
For subscribers
Analyst: Wegovy prescriptions continue upward trend in US
For subscribers
JPMorgan: Novo Nordisk to accelerate growth this year
For subscribers
.jpg&w=384&q=75)
